 LONDON--BUSINESS WIRE--Theramex, a global company specialised in womens health, announced today the Decentralised Procedure approval in several EU countries and the UK of BIJUVA 1 mg estradiol 100 mg progesterone capsules for the indication of continuous combined hormone replacement therapy HRT for estrogen deficiency symptoms in postmenopausal women with intact uterus and with at least 12 months since last menses. Up to 80 of women experience vasomotor symptoms during their menopau 